Back to Search
Start Over
Effects of febuxostat on delaying chronic kidney disease progression: a randomized trial in China.
- Source :
- International Urology & Nephrology; May2023, Vol. 55 Issue 5, p1343-1352, 10p
- Publication Year :
- 2023
-
Abstract
- Background: A few studies have tested febuxostat for its usefulness in delaying chronic kidney disease (CKD) progression by treating hyperuricemia and results were controversial. Thus, we attempted to conduct a randomized controlled study using the Chinese population with advanced grade of CKD. Methods: One hundred CKD patients in stages 3 and 4 with asymptomatic hyperuricemia from seven medical centers were included in this prospective randomized controlled study and assigned to the control and febuxostat group, the latter of which received febuxostat to titrate to achieve serum uric acid (SUA) < 6 mg/dL. The observation period was 12 months. The primary outcomes included the event of estimated glomerular filtration rate (eGFR) decline ≥ 30% or 50% from baseline at 12 months, dialysis and death from CKD; secondary outcome was the change in eGFR. Safety analysis was also performed. Results: Forty-seven patients and 45 patients in the febuxostat and control groups, respectively completed the study. Seven of 47 (14.9%) participants reached 30% decline in eGFR in the febuxostat group, while 1 (2.1%) and 2 (4.3%) patients reached 50% decline in eGFR or dialysis. Thirteen (28.9%), 10 (22.2%) and 3 (6.7%) of 45 patients reached primary kidney outcomes separately in the control group. The change in eGFR after 12 months from baseline in the febuxostat group was 0.50 mL/min/1.73 m<superscript>2</superscript>, which was significantly higher than that in the control group − 4.46 mL/min/1.73 m<superscript>2</superscript> (p = 0.006). Adverse events did not differ between two groups. Conclusions: Febuxostat effectively slowed eGFR decline in patients with CKD stages 3 and 4 and asymptomatic hyperuricemia. [ABSTRACT FROM AUTHOR]
Details
- Language :
- English
- ISSN :
- 03011623
- Volume :
- 55
- Issue :
- 5
- Database :
- Complementary Index
- Journal :
- International Urology & Nephrology
- Publication Type :
- Academic Journal
- Accession number :
- 163122090
- Full Text :
- https://doi.org/10.1007/s11255-022-03437-5